Who we are

Medical science is a detective that tries to understand what goes on in the human body. Medicine still has a very limited in knowledge of what occurs inside the body as we are immensely complex.

At Newbery Medicine we understand the practice of medicine as a way to help people facilitate the amazingly complex capacity of the human body for repairing itself. We do not envision our treatment as “curative”. Cure is a state that only the body can achieve by itself. So our actions and advice acts as an enhancement to the natural mechanisms the body posses.

Newbery Medicine is dedicated to understanding and treating inflammatory conditions. Inflammation is a new approach to a more classical view of the “autoimmune diseases”. It involves a great amount of ailments that share in common multiple medical conditions.

Many of these “inflammatory diseases” have shown a common pattern: they have unbalanced gut microorganisms. Even diseases like psoriasis, multiple sclerosis or rheumatoid arthritis, which we would think originate far away from the gut, share similar patterns of abnormal microbial populations.

The treatments available for the ever-increasing number of inflamed patients tend to grow in aggressiveness and invasiveness over already frail bodies. The therapeutic techniques generally used have very poor results and expose the patient to enormous risks without the corresponding efficiency. This equation of low efficiency at a high risk is very discouraging for many. Furthermore, the costs of these new therapeutic techniques are soaring, which inflicts an extra burden to patients who have to pay for them.

Our first experience with FMT was with a couple who’s daughter had Crohn’s disease. They did not want to expose her to the drugs offered by their gastroenterologist. We treated her with FMTs and she was able to control the inflammation (she normalized her Fecal Calprotectin) and form stools for the first time in her life among many other improvements. There were no side effects to this therapy.

The good results we obtained with this novel approach led to the creation of Newbery Medicine and its team of specialists, dedicated exclusively to treat inflammatory diseases. The results we are seeing are very encouraging.

Most treatments applied in chronic diseases should in general be maintained throughout the life of the sufferer. Just as diabetic insulin must be used during a patient´s entire life, it seems as though anti-inflammatory therapies should be used for extended periods of time, in the very few cases where they are effective.

The therapeutic approach for Ulcerative Colitis used by mainstream medicine today resides in two approaches: one is the modification of the immunologic response via “biologic drugs” and the other is to “cure” the body by surgically amputating the large intestine (colectomy) where the disease is supposed to reside. But to the great surprise of many patients who opt for the surgical “solution”, they end up with the same predicament. In fact they are in worse condition as they have lost their colon, the place where the real solution to their problem resides. We see it repeatedly: once the colon is removed patients experience some relief for a short period of time, after which their symptoms return and new problems appear.

It is now known that this disease resides throughout the body. Inflammation of the bowel is just the organ where this process is expressed. However, many patients show not only gut problems, but also issues in the liver, eyes, joints, skin, blood – the list goes on – which are associated with their intestinal problems. These additional intestinal symptoms do not improve after the gut removal.

The quality of life of a patient suffering from ulcerative colitis or Crohn’s disease is very poor. They live in terror of not being able to reach the bathroom in time, of having to use diapers, and of experiencing pain before, during and after a bowel movement. Crohn´s patients usually need to receive surgical procedures to relieve obstructions of fistulas, and thus gradually lose parts of their gut. They usually bleed, have anemia, and may need blood replacement. It is difficult for younger patients to thrive since they can´t maintain weight. They are malnourished and they suffer many other dangerous health situations.

The therapeutic approach to help them should avoid adding new problems to the already existing ones. The available drugs so far are ineffective and involve a high risk. They have very low efficacy, as good responses are achieved in only about 41-42% of all cases where the best therapeutic approach to control of inflammation is used. In cases where other therapeutic approaches are used, about 60% of all treated patients do not show any positive response to medications. This would be tolerable if, despite having low effectiveness, they would entail low risk. But most of the drugs used to treat inflammation have very high risks.

Any medical intervention on the body involves some degree of risk. Anything from surgery to using an “innocent” vitamin as medication involves intervening in a complex system. Every action entails a huge number of possible complex reactions. The more aggressive the action, the greater the risk. Overall risk is viewed as a necessary evil to cure major diseases. However, when curing minor illnesses such as inflammation, if the possible outcome is cancer, then the application of that method or drug has no justification.

The great contribution of recent years has been the discovery of a huge number of microscopic inhabitants over and in our bodies denominated microbiota. One of the most crucial ones is the intestinal bacterial population which weights about one kilo and mainly resides in our colon.

The transplant of bacteria from a healthy donor to a sick patient has been shown to be a very successful approach to treating one disease; the Clostridium Difficile infection. Many other diseases, including inflammatory bowel, are showing extremely good results to the initial treatments. A great deal of research is still under way, the most striking feature of this therapy aside from the surprisingly good outcomes, is that it is safe. Only minor problems have been reported as negative outcomes, never has an important infection or death resulted from this approach.

Therefore, in Newbery Medicine we are dedicated to treating people with intestinal inflammation and other inflammatory diseases using this novel technique. The list of inflammatory diseases continues to grow, and the procedure and preparation of the recipients becomes increasingly more sophisticated.

Newbery Medicine was founded by Dr. Silvio Najt (1952 – 2016), a recognized leader in the development of FMT protocols. Dr. Najt began his investigation into IBD in connection to his own child’s. He had some success through dietary changes and supplements other than the traditional immunosuppressant medications, but these protocols were not controlling the underlying inflammation. After discovering the work of Professor Thomas Borody in Sydney, Dr. Najt immediately saw that fecal transplants made great sense. Until then, the only intervention in gut bacteria—one of the key components of the perpetuation of inflammation— were diet and pre- or probiotics. FMT was a very effective way of transforming the “bacterial organ.”

As a continuation of his research, Dr. Najt created Newbery Medical, made up of a team of medical professionals, specialists in bacteriology and infectious disease control. Together, they developed the pioneering FMT treatment protocols that have been so successful with Newbery´s patients. The philosophy of the team is that every patient is unique and requires personalized attention. Newbery Medicine was created to provide a comfortable environment where we can optimize the health of each patient according to their specific needs.